発熱性物質試験の世界市場：2019年～-2023年

世界の発熱性物質試験市場では、様々な疾患を治療するためのバイオ医薬品に対する需要が高まっています。技術の進歩と革新的な製品の発売が市場成長を推進していますが、動物管理分野での製品リコールの増加が市場の成長を妨げている主な要因の1つとなっています。

当レポートでは、世界の発熱性物質試験市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

• イントロダクション1
• イントロダクション2
• 米ドルの通貨換算レート

第3章 市場状況

• 市場エコシステム
• 市場の特徴
• 市場セグメンテーション分析

第4章 市場規模

• 市場の定義
• 市場規模（2018年）
• 市場規模および予測（2018年～2023年）

第5章 ファイブフォース分析

• バイヤーの交渉力
• サプライヤーの交渉力
• 新規参入の脅威
• 代替品の脅威
• 競争相手の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメンテーション：エンドユーザー別
• エンドユーザー別比較：市場規模および予測（2018年～2023年）
• 製薬およびバイオテクノロジー企業
• 医療機器企業
• 食品・飲料メーカー
• 市場機会：エンドユーザー別

第7章 顧客情勢

第8章 地域情勢

• 地域別セグメンテーション
• 地域別比較：市場規模および予測（2018年～2023年）
• 北米
• 欧州
• アジア
• その他の地域
• 主要国
• 市場機会

第9章 成長要因と課題

• 市場成長要因
• 市場の課題

第10章 市場動向

第11章 ベンダー情勢

• 概要
• 創造的破壊の状況

第12章 ベンダー分析

• 対象ベンダー
• ベンダー分類
• ベンダーの市場ポジショニング
• Charles River
• GenScript
• Lonza
• Merck KGaA
• Thermo Fisher Scientific Inc.

第13章 付録

• 調査方法
• 略語のリスト

About this market

Pharmaceutical and biotechnology companies, as well as research institutes, worldwide are increasingly focusing and spending on R&D for drug discovery and development due to the rising prevalence of chronic diseases. Such an increase in the number of projects fuels the demand for pyrogen testing products as these products are vital in analyzing and detecting the bacterial toxins in the raw materials used for the production of medicines. This further leads to the high-volume generation of pyrogen testing products by various manufacturers. Thus, an increase in R&D spending in the pharmaceutical industry results in the development of new drugs. Such benefits have resulted in increased outsourcing to meet the rising global demand for new drugs, which will drive the growth of the global pyrogen testing market during the forecast period. Technavio's analysts have predicted that the pyrogen testing market will register a CAGR of over 12% by 2023.

Market Overview

Growing preference for value-added services

Vendors in the global pyrogen testing market are increasingly focusing on providing additional software along with pyrogen testing systems to successfully integrate the results obtained using these systems into the existing laboratory workflow and to record data for use at a later stage for R&D studies. Data integration is the key factor here as the data generated by pyrogen testing products need to be collated with other exploratory data to generate actionable insights and progress toward informed decision-making.

Stringent regulatory policies

Manufacturers are affected by the stringent government regulations that control the manufacture, distribution, marketing, and sales of drugs and medical devices. The stringent regulations are expected to hinder the growth of the global pyrogen testing market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the pyrogen testing market during the 2019-2023, view our report.

Competitive Landscape

The pyrogen testing market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1. Preface
• 2.2. Preface
• 2.3. Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY END-USER

• Market segmentation by end-user
• Comparison by end-user
• Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
• Medical devices companies - Market size and forecast 2018-2023
• Food and beverage manufacturers - Market size and forecast 2018-2023
• Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Charles River
• GenScript
• Lonza
• Merck KGaA
• Thermo Fisher Scientific Inc.

PART 13: APPENDIX

• Research methodology
• List of abbreviations

List of Exhibits

• Exhibit 01: Global healthcare market
• Exhibit 02: Segments of global healthcare market
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Market definition - Inclusions and exclusions checklist
• Exhibit 06: Market size 2018
• Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
• Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
• Exhibit 09: Five forces analysis 2018
• Exhibit 10: Five forces analysis 2023
• Exhibit 11: Bargaining power of buyers
• Exhibit 12: Bargaining power of suppliers
• Exhibit 13: Threat of new entrants
• Exhibit 14: Threat of substitutes
• Exhibit 15: Threat of rivalry
• Exhibit 16: Market condition - Five forces 2018
• Exhibit 17: End-user - Market share 2018-2023 (%)
• Exhibit 18: Comparison by end-user
• Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
• Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
• Exhibit 21: Medical devices companies - Market size and forecast 2018-2023 ($ millions)
• Exhibit 22: Medical devices companies - Year-over-year growth 2019-2023 (%)
• Exhibit 23: Food and beverage manufacturers - Market size and forecast 2018-2023 ($ millions)
• Exhibit 24: Food and beverage manufacturers - Year-over-year growth 2019-2023 (%)
• Exhibit 25: Market opportunity by end-user
• Exhibit 26: Customer landscape
• Exhibit 27: Market share by geography 2018-2023 (%)
• Exhibit 28: Geographic comparison
• Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
• Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
• Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
• Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
• Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
• Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
• Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
• Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
• Exhibit 37: Key leading countries
• Exhibit 38: Market opportunity
• Exhibit 39: Advantages of using software with pyrogen testing systems
• Exhibit 40: Impact of drivers and challenges
• Exhibit 41: Vendor landscape
• Exhibit 42: Landscape disruption
• Exhibit 43: Vendors covered
• Exhibit 44: Vendor classification
• Exhibit 45: Market positioning of vendors
• Exhibit 46: Charles River - Vendor overview
• Exhibit 47: Charles River - Product segments
• Exhibit 48: Charles River - Organizational developments
• Exhibit 49: Charles River - Geographic focus
• Exhibit 50: Charles River - Segment focus
• Exhibit 51: Charles River - Key offerings
• Exhibit 52: GenScript - Vendor overview
• Exhibit 53: GenScript - Business segments
• Exhibit 54: GenScript - Organizational developments
• Exhibit 55: GenScript - Geographic focus
• Exhibit 56: GenScript - Segment focus
• Exhibit 57: GenScript - Key offerings
• Exhibit 58: Lonza - Vendor overview
• Exhibit 59: Lonza - Business segments
• Exhibit 60: Lonza - Organizational developments
• Exhibit 61: Lonza - Geographic focus
• Exhibit 62: Lonza - Segment focus
• Exhibit 63: Lonza - Key offerings
• Exhibit 64: Merck KGaA - Vendor overview
• Exhibit 65: Merck KGaA - Business segments
• Exhibit 66: Merck KGaA - Organizational developments
• Exhibit 67: Merck KGaA - Geographic focus
• Exhibit 68: Merck KGaA - Segment focus
• Exhibit 69: Merck KGaA - Key offerings
• Exhibit 70: Thermo Fisher Scientific Inc. - Vendor overview
• Exhibit 71: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 72: Thermo Fisher Scientific Inc. - Organizational developments
• Exhibit 73: Thermo Fisher Scientific Inc. - Geographic focus
• Exhibit 74: Thermo Fisher Scientific Inc. - Segment focus
• Exhibit 75: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 76: Validation techniques employed for market sizing